Dupixent® (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old 68% of children on a higher dose of Dupixent achieved histological disease… Read More
The PRAME (EPR20330) Antibody evaluates PRAME protein expression from patients with suspected melanoma. Understanding if the PRAME protein is expressed helps enable more informed clinical decisions and may improve patient… Read More
Integrating Research Innovation and Health Care Research has a profound impact on patient care and population health, and leads to a greater understanding of diseases, life-saving treatments and preventative strategies… Read More
Evonik to produce commercial quantities of the drug substance vonoprazan for use in VOQUEZNA™ TRIPLE PAK™ and DUAL PAK™, and other products containing vonoprazan Supply security through production at sites… Read More
RAHWAY, NJ — Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been named to Fortune’s 2022 Change the World list. The annual list recognizes companies… Read More
